High time to study aortic stenosis in the Japanese  by Uematsu, Masaaki
Journal of Cardiology 65 (2015) 351–352Editorial
High time to study aortic stenosis in the Japanese
Keywords:
Aortic stenosis
Echocardiography
Japanese
Degenerative calciﬁcation
Risk factors
Contents lists available at ScienceDirect
Journal of Cardiology
jo u rn al h om ep age: ww w.els evier .c o m/lo c ate / j j c cAortic stenosis (AS) has been the most common form of valvular
heart disease in the past decades. Clinicians are well aware that
acutely decompensated AS is resistant to medical therapy because
of the mechanical obstruction in the left ventricular outﬂow.
Determining the timing of surgery remains an important issue in
the management of otherwise healthy, asymptomatic AS patients
because the progression of AS may vary from patient to patient.
Left ventricular outﬂow is obstructed due to the degenerative
calciﬁcation of the aortic cusps. Interestingly, similar to the
cardiovascular risk factors deﬁned by the Framingham study for
vascular atherosclerosis, clinical factors associated with the
presence of calciﬁc aortic valve disease in the Cardiovascular
Health Study included older age, male sex, serum lipoprotein(a)
and low-density lipopoproetin levels, height, hypertension,
metabolic syndrome, and smoking [1]. Pathogenesis of the
degenerative calciﬁcation of the aortic valve comprises complex
processes, which include multifaceted hemodynamic and cellular
mechanisms. Multiple cells such as endothelial cells, monocytes,
macrophages, and myoﬁbroblasts are involved in the processes.
Lipids, renin-angiotensin signaling pathway, and oxidative stress
play a role. Thus, genetic factors and environmental background
may inﬂuence the pathogenesis of AS. Although clinical data on AS
have been accumulating mainly in North America and in Western
Europe [2], these data may not be necessarily extrapolated to the
Japanese population because of the differences in the social and
behavioral environments as well as in the genetic factors. The
Japanese in general have smaller body mass index, and higher
sodium intake, and they lead more sedentary lives in their later
years than most of the Westerners.
In this article of the Journal of Cardiology, Miura et al.
investigated the mortality, cause of death, clinical event rates,
and prognostic factors in 519 consecutive patients with severe AS
(aortic valve area < 0.1 cm2) referred to a tertiary medical center in
Kitakyushu for median follow up of 3.5 years [3]. Although this is a
single center experience, the follow-up rate was strikingly high at
97%. One-third of the population died during the follow up. As
expected, patients enrolled were predominantly elderly (mean
age = 78 years), associated with multiple comorbidities, and werehttp://dx.doi.org/10.1016/j.jjcc.2015.03.001
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cause of death. Factors such as severe symptomatic status, lower
daily activity levels, and chronic kidney diseases were the strong
predictors of poor survival. These results were expected and not
surprising at all, but it is interesting to note that authors found
surprisingly low occurrence of syncope (4%) during 3.5 years of
follow up compared to earlier studies. The authors attributed the
difference to the patient population in their study, which included
a fair number of asymptomatic patients. They also speculated that
close follow up by experts in a large-volume tertiary center, as
evidenced by the high follow-up rate, possibly prevented syncope
because syncope occurred 1.8 years following the occurrence of
angina on average. Recently, valvuloarterial impedance, rather
than AS severity, has been reported to predict syncope in patients
with AS [4]. It is interesting to speculate that modiﬁcation of
hemodynamics by medical management including the inhibition
of renin-angiotensin system, for example, may have prevented the
occurrence of syncope.
Another interesting point the authors found was that the
survival rate was not as ‘‘pessimistic’’ as previously reported
among those who did not undergo aortic valve replacement.
Difference in etiology of AS (including a large number of non-
rheumatic, non-congenital AS) as well as the improvement in
medical management was suggested by the authors for the
explanation. In addition, genetic factors and social and behavioral
environments in Japan may also play a role in the ‘‘not so
pessimistic’’ prognosis of AS. It is interesting to speculate that
mentally and physically supportive society to the elderly may have
led to the better outcome in contrast to the Western countries
although these socio-environmental situations may change rapidly
in the not-so-distant future. Further large-scale multicenter
registry studies may clarify these social and behavioral factors
affecting AS in the Japanese.
Obesity was raised as one of the risk factors for AS in the
Western countries although controversies exist [5–7]. It is
noteworthy that body mass index (BMI) was 22.0  4.1 in this
study by Miura et al. Although BMI was not different between the
non-survivors and the survivors, it may be possible that survivors had reserved.
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excluded. Given these, small BMI might lead to better outcome in AS
patients in spite of the small oriﬁce area through less demand for
cardiac output.
Although age-related degenerative calciﬁcation may be a major
cause of adult AS, we should also bear in mind that AS may be
congenital in origin, such as bicuspid aortic valve, and that it also
occurs secondary to rheumatic inﬂammation [8,9]. Although these
may share common degenerative calciﬁcation pathways during
the worsening of the stenosis, they may differ in clinical course. It
may be difﬁcult to clinically differentiate AS of different etiology in
the advanced stage, but we should be aware in the research as well
as in the clinical settings that the difference in etiology exists.
Echocardiography is a robust clinical tool for the assessment of
hemodynamic as well as anatomic changes in AS. Current
guidelines recommend measurement of peak aortic jet velocity
obtained by a continuous wave Doppler technique, mean pressure
gradient calculated by using simpliﬁed Bernoulli equation, and
valve area based on continuity equation [10]. More recently, low-
ﬂow, low-gradient AS has been highlighted [11–13]. Basically, it is
the AS with a small left ventricular stroke volume and a small
oriﬁce area, but the clinical outcome remains controversial.
Although surgical aortic valve replacement is a well-established
mode of therapy, transcatheter techniques for aortic valve
replacement have recently been introduced [14]. These less
invasive new modes of therapy would change the indication of
valve replacement, and eventually change the management of
patients with AS, particularly in the elderly. Repeated open heart
surgery is extremely difﬁcult to perform, but with a new
transcatheter technique, valve-in-valve therapy has become
possible [15]. We need to understand the current pathophysiologic
status of and prognostic statuses of AS patients correctly for the
better management of AS patients in the future by making the most
of these new techniques.
Japan is a country that harbors one of the most aging societies in
the world. Apart from the genetic issues, studies on AS in Japan
would provide valuable information on the pathophysiology of AS
in an aging society. Basic as well as clinical studies on AS should be
pursued in this environment. It is high time to study AS in Japan.
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